An AAV-derived Apaf-1 Dominant Negative Inhibitor Prevents MPTP Toxicity as Antiapoptotic Gene Therapy for Parkinson's Disease

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.191107398
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Gene Disruption of Caspase-3 Prevents MPTP-induced Parkinson’s Disease in Mice

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2010English

Reassessment of Subacute MPTP-treated Mice as Animal Model of Parkinson's Disease

Acta Pharmacologica Sinica
MedicinePharmacology
2017English

MRI-guided Phase 1 Trial of Putaminal AADC Gene Therapy for Parkinson's Disease

Annals of Neurology
Neurology
2019English

A Dominant Negative Inhibitor Indicates That Monocyte Chemoattractant Protein 1 Functions as a Dimer.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1995English

Protumorigenic Activity of Plasminogen Activator Inhibitor-1 Through an Antiapoptotic Function

Journal of the National Cancer Institute
Cancer ResearchOncology
2012English

200. Advancing a State of the Art Gene Therapy for Parkinson's Disease

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2013English

AAV Gene Therapy Corrects OTC Deficiency and Prevents Liver Fibrosis in Aged OTC-knock Out Heterozygous Mice

Molecular Genetics and Metabolism
GeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2017English

659. Development of an Effective AAV Vector-Based Gene Therapy to Treat the PRKAG2-Tg Mice, an Animal Model of Autosomal Dominant Progressive Cardiomyopathy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy